China Approval Watch: September Dominated By Generics And Vaccines
Twenty-three chemical drugs, three biologics and one traditional Chinese medicine are among the latest approvals granted by the China FDA, which is continuing on a hiring spree to increase its number of reviewers.
You may also be interested in...
China Regulatory Watch is our new snapshot of product-specific regulatory developments at the China FDA.
The Chinese Society of Clinical Oncology (CSCO) annual meeting, against the background of the global pandemic, has one clear message that local researchers and players are pressing ahead to take a leadership role in cutting-edge cancer research globally.
Frank Zhang, co-founder and chair of the Hong Kong-listed Chinese biotech Genscript, parent of Nasdaq-listed cell therapy star, Legend Biotech, has been detained by Chinese authorities, along with four employees.